Page last updated: 2024-09-04

satavaptan and Acute Kidney Failure

satavaptan has been researched along with Acute Kidney Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jepsen, P; Vilstrup, H; Watson, H; Wong, F1
Bernard, A; Bonventre, JV; Chagnon, F; Guindi, C; Lesur, O; Plante, GE; Vaidya, VS1

Trials

1 trial(s) available for satavaptan and Acute Kidney Failure

ArticleYear
Un-precipitated acute kidney injury is uncommon among stable patients with cirrhosis and ascites.
    Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:10

    Topics: Acute Kidney Injury; Aged; Ascites; Creatinine; Diuretics; Female; Humans; Internationality; Liver Cirrhosis; Male; Middle Aged; Morpholines; Paracentesis; Prognosis; Proportional Hazards Models; Severity of Illness Index; Spiro Compounds

2018

Other Studies

1 other study(ies) available for satavaptan and Acute Kidney Failure

ArticleYear
Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge.
    Critical care medicine, 2008, Volume: 36, Issue:11

    Topics: Acute Kidney Injury; Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Creatinine; Endotoxins; Epinephrine; Glomerular Filtration Rate; Injections, Intraperitoneal; Kidney; Lipopolysaccharides; Male; Morpholines; Proteinuria; Random Allocation; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Circulation; RNA, Messenger; Sepsis; Spiro Compounds; Uteroglobin; Vasoconstrictor Agents

2008